Other equities research analysts have also issued research reports about the stock. BidaskClub raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Thursday, November 21st. Raymond James upped their price objective on shares of ICU Medical from $185.00 to $203.00 and gave the stock a “positive” rating in a report on Tuesday, November 12th. Zacks Investment Research downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 14th. Finally, TheStreet lowered shares of ICU Medical from a “b-” rating to a “c+” rating in a report on Monday, August 12th. One analyst has rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $242.00.
Shares of ICU Medical stock opened at $179.16 on Tuesday. ICU Medical has a 12 month low of $148.89 and a 12 month high of $259.72. The firm has a market capitalization of $3.83 billion, a P/E ratio of 23.24 and a beta of 0.92. The business has a fifty day simple moving average of $174.23 and a two-hundred day simple moving average of $195.73.
In other ICU Medical news, Director George A. Lopez sold 20,000 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $184.29, for a total value of $3,685,800.00. Following the sale, the director now directly owns 368,864 shares of the company’s stock, valued at $67,977,946.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert S. Swinney sold 373 shares of the stock in a transaction on Monday, October 14th. The stock was sold at an average price of $153.49, for a total value of $57,251.77. Following the completion of the sale, the director now directly owns 18,845 shares in the company, valued at $2,892,519.05. The disclosure for this sale can be found here. 11.40% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Advisory Services Network LLC increased its position in shares of ICU Medical by 70.2% during the second quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock valued at $36,000 after acquiring an additional 59 shares in the last quarter. Quadrant Capital Group LLC lifted its position in ICU Medical by 1,389.5% in the 3rd quarter. Quadrant Capital Group LLC now owns 283 shares of the medical instruments supplier’s stock valued at $43,000 after acquiring an additional 264 shares in the last quarter. Quest Capital Management Inc. ADV purchased a new stake in ICU Medical during the 3rd quarter valued at $80,000. Huntington National Bank boosted its stake in ICU Medical by 17.9% during the 3rd quarter. Huntington National Bank now owns 559 shares of the medical instruments supplier’s stock valued at $89,000 after purchasing an additional 85 shares during the last quarter. Finally, DRW Securities LLC purchased a new stake in ICU Medical during the 2nd quarter valued at $204,000. 91.85% of the stock is owned by hedge funds and other institutional investors.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Featured Article: Yield Curve
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.